Dr. Buss is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
800 Washington Street, Box 189
Tufts Medical Center
Boston, MA 02111Phone+1 617-636-7957Fax+1 617-636-9080- Is this information wrong?
Summary
- Dr. Mary Buss is a palliative care physician and medical oncologist in Boston, MA. She graduated from Williams College with a degree in Bio-Medical Ethics and received her medical degree from Georgetown University School of Medicine. After residency at the University of Pittsburgh, she came to Beth Israel Deaconess Medical Center for fellowship training. As faculty there, she started the outpatient palliative care practice and the Palliative Medicine fellowship. In 2022, she joined Tufts Medical Center to expand their palliative care clinical practice and educational footprint. She has expertise in pain and symptom management and communication skills training. Her scholarly work focuses on developing models to enhance delivery and integration of palliative care.
Education & Training
- Harvard School of Public HealthMPH, Clinical Effectiveness, 2003 - 2007
- Massachusetts General Hospital/Dana-Farber Cancer Institute/Brigham and Women's HospitalFellowship, Hospice and Palliative Medicine, 2003 - 2004
- Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2001 - 2003
- UPMC Medical EducationResidency, Internal Medicine, 1997 - 2000
- Georgetown University School of MedicineClass of 1997
- Williams CollegeBA, Bio-Medical Ethics, Cum Laude, 1989 - 1993
Certifications & Licensure
- MA State Medical License 2001 - 2026
- PA State Medical License 1998 - 2002
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Cunniff-Dixon Physician Award The Hastings Center, 2015
Clinical Trials
- Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer Start of enrollment: 2010 Apr 14
- Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer Start of enrollment: 2016 Nov 14
Publications & Presentations
PubMed
- Reflections on Palliative Medicine Turning Sweet Sixteen.Mary K Buss> ;Journal of Pain and Symptom Management. 2024 Apr 1
- 4 citationsShould Outpatient Palliative Care Clinics in Cancer Centers be Stand Alone or Embedded?Camilla Zimmermann, Mary K Buss, Michael W Rabow, Breffni Hannon, David Hui> ;Journal of Pain and Symptom Management. 2023 Feb 1
- 3 citationsOncology Fellows' Clinical Discussions, Perceived Knowledge, and Formal Training Regarding Medical Cannabis Use: A National Survey Study.Rushad Patell, Poorva Bindal, Laura Dodge, Pavania Elavalakanar, Jason A Freed, Deepa Rangachari, Mary Buss, Mara Schonberg, Ilana Braun> ;JCO Oncology Practice. 2022 Nov 1
- Join now to see all
Press Mentions
- ‘Curiosity Is the Cure': Local Experts Discuss Hurdles Facing Cannabis in Health CareMarch 27th, 2023
- Moral Distress in NeurosurgeryAugust 15th, 2019
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: